P1-169A novel CSF1R-c-kit dual antagonist eliminates tumor associated macrophage without elevating intratumoral MDSC level
Abstract Results After review of the pre-specified IA, the IDMC recommended full analysis and disclosure of the results. With 256 IDFS events reported, administration of T-DM1 significantly improved IDFS compared with trastuzumab (unstratified HR = 0.50; 95% CI: 0.39 to 0.64; p
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2019-10, Vol.30 (Supplement_6) |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Results
After review of the pre-specified IA, the IDMC recommended full analysis and disclosure of the results. With 256 IDFS events reported, administration of T-DM1 significantly improved IDFS compared with trastuzumab (unstratified HR = 0.50; 95% CI: 0.39 to 0.64; p |
---|---|
ISSN: | 0923-7534 1569-8041 |
DOI: | 10.1093/annonc/mdz343.036 |